Related Experiment Video
Updated: Sep 20, 2026

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction
Published on: June 29, 2013
Intrauterine undernutrition and programming as a new risk of cardiovascular disease in later life
P Szitányi1, J Janda, R Poledne
1First Department of Pediatrics, Second Medical School, Charles University, University Hospital Motol, V úvalu 84, 150 06 Prague 5, Czech Republic. szitanyi@yahoo.com
Insights
Intrauterine undernutrition can program risk factors for cardiovascular disease, including hypertension and impaired cholesterol and glucose metabolism. These fetal programming effects contribute to atherosclerosis development later in life.
Area of Science:
- Cardiovascular Science
- Developmental Biology
- Nutritional Science
Background:
- Atherosclerosis is a complex, multifactorial disease with origins potentially in utero.
- Cardiovascular disease remains a leading cause of mortality in adulthood.
- The precise role of early-life factors in atherosclerosis pathogenesis requires further elucidation.
Purpose of the Study:
- To review the potential impact of intrauterine undernutrition on the development of cardiovascular disease risk factors.
- To explore the mechanisms by which fetal undernutrition may program long-term metabolic and vascular health.
- To synthesize evidence on the synergistic role of intrauterine undernutrition with other risk factors.
Main Methods:
- Literature review of experimental and human studies.
- Analysis of research investigating fetal growth and metabolic programming.
- Synthesis of data on the long-term health consequences of intrauterine undernutrition.
Main Results:
- Intrauterine undernutrition is linked to altered fetal growth and metabolism.
- Evidence suggests programming of hypertension, impaired cholesterol, and glucose metabolism.
- Fetal undernutrition acts synergistically with genetic and environmental factors in atherosclerosis development.
Conclusions:
- Intrauterine undernutrition is a significant factor in the pathogenesis of atherosclerosis.
- Fetal undernutrition can lead to permanent alterations in health status, increasing cardiovascular risk.
- Early-life nutritional interventions may be crucial for preventing adult cardiovascular disease.
Abstract:
It is believed that atherogenesis is a multifactorial process, which could already start in utero. Development of atherosclerosis progresses over decades and leads to the cardiovascular morbidity and mortality in adulthood. At present, we have no exact explanation for all the risk factors acting in the pathogenesis of atherosclerosis. This review should provide an overview about the possible role of intrauterine undernutrition in the development of risk factors for cardiovascular disease. Intrauterine undernutrition leads to changes in fetal growth and metabolism and programs later development of some of these risk factors. A number of experimental and human studies indicates that hypertension as well as impaired cholesterol and glucose metabolism are affected by intrauterine growth. Intrauterine undernutrition plays an important role and acts synergistically with numerous genetic and environmental factors in the development of atherosclerosis. There is evidence that undernutrition of the fetus has permanent effects on the health status of human individuals.
Related Concept Videos
Coronary Artery Disease I: Introduction
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Type II Diabetes I: Introduction
Diabetes Mellitus: Type 2 and Gestational
Coronary Artery Disease II: Pathophysiology
